SINGAPORE, May 18 (Reuters) – Singapore has authorised the usage of the Pfizer-BioNTech COVID-19 vaccine for these aged 12 to 15 years outdated in a bid to prolong safety to extra teams because the nation tackles a latest enhance of infections, officers stated on Tuesday.
“The data showed that the Pfizer-BioNTech COVID-19 vaccine demonstrated high efficacy consistent with that observed in the adult population,” the well being ministry stated in an announcement, including “its safety profile is also consistent with the known safety profile in the adult population”.
The authorities may even prolong the interval between two-dose COVID-19 vaccines to six to eight weeks, from three to 4 weeks presently, it stated.
Read all of the Latest News, Breaking News and Coronavirus News right here
